Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1341 USD | -2.05% | -10.60% | -31.23% |
May. 30 | Transcript : CytoDyn Inc. - Special Call | |
May. 03 | CytoDyn Inc. announced that it has received $8.942 million in funding | CI |
Financials (USD)
Sales 2022 | 0.27 | Sales 2023 | - | Capitalization | 239M |
---|---|---|---|---|---|
Net income 2022 | -211M | Net income 2023 | -79M | EV / Sales 2022 | 989,524,989 x |
Net Debt 2022 | 32.57M | Net Debt 2023 | 33.01M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.02
x | P/E ratio 2023 |
-2.52
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.15% |
Latest transcript on CytoDyn Inc.
1 day | -2.05% | ||
1 week | -10.60% | ||
Current month | -15.02% | ||
1 month | -20.23% | ||
3 months | -19.94% | ||
6 months | -32.88% | ||
Current year | -31.23% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | Nov. 16 | |
Mitchell Cohen
DFI | Director of Finance/CFO | 68 | Jan. 31 |
Scott Hansen
CTO | Chief Tech/Sci/R&D Officer | - | 23-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Simes
BRD | Director/Board Member | 72 | 22-10-12 |
Ryan Dunlap
BRD | Director/Board Member | 54 | 22-08-23 |
Karen Brunke
BRD | Director/Board Member | 72 | 22-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 0.1341 | -2.05% | 3,709,408 |
24-06-13 | 0.1369 | -0.15% | 2,480,695 |
24-06-12 | 0.1371 | -2.28% | 3,112,714 |
24-06-11 | 0.1403 | -6.47% | 9,213,058 |
24-06-10 | 0.15 | 0.00% | 2,369,998 |
Delayed Quote OTC Markets, June 14, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-31.23% | 145M | |
+18.15% | 124B | |
+18.02% | 111B | |
-12.75% | 23.17B | |
+5.07% | 22.94B | |
-39.94% | 17.42B | |
-9.86% | 17.42B | |
-14.97% | 16.9B | |
+2.80% | 13.71B | |
+27.39% | 11.82B |
- Stock Market
- Equities
- CYDY Stock